Financial Highlights

Financial Highlights

2020 2019 2018
Revenue S$123.7m S$119.4m S$120.9m
EBITDA S$9.3m S$10.1m S$8.0m
Net Profit S$6.2m S$6.5m S$5.4m*
EPS 2.05 cents 2.17 cents 1.95 cents
NAV per share 15.7 cents 14.7 cents 13.1 cents
Operating cash flow S$4.1m S$9.5m S$7.5m
Gearing ratio 5.1% 0.7% 7.7%
Dividends per share 0.62 cents^ 1 cent 0.55 cents

* Include IPO expense S$0.9 million.
^ The proposed dividend is subject to the approval of shareholders at the forthcoming Annual General Meeting

Revenue by Business Segments

S$ million FY2020 FY2019 FY2018
Specialty pharma principals 64.6 65.1 69.4
Proprietary brands 18.2 14.5 13.2
Medical hypermart & digital 40.9 39.8 38.3
Total revenue 123.7 119.4 120.9

Revenue by Countries

S$ million FY2020 FY2019 FY2018
Singapore 60.8 57.5 53.9
Vietnam 46.6 46.7 52.7
Malaysia 7.9 8.0 7.6
Others 8.4 7.2 6.7
Total revenue 123.7 119.4 120.9